First, we observed the up-regulation of IFIT3 in our PDAC cell line L3.6pl and the patient-derived primary tumor cell line TBO368 after gemcitabine treatment at both the mRNA and protein level (Figure 2A-B). Here, IFIT3 is linked to neoplasm.